Physician profile
Matthew Connor
NPI 1427429943
$1,737.92
in general payments reported to CMS, 2019-2025
13 companies · $593 in 2025
The $593 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.46 · 2022: $416 · 2023: $369 · 2024: $266 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $624.77 | 2021-2025 | Aveir, Tendril, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $426.84 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $184.28 | 2022-2025 | Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device |
| Medtronic, INC. | $172.14 | 2021-2023 | Mycarelink |
| Novartis Pharmaceuticals Corporation | $79.57 | 2022-2024 | |
| Cardiva Medical, INC. | $56.85 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 5f Vcs |
| Pfizer INC. | $54.46 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $48.96 | 2022 | |
| Vital Connect, INC | $27.53 | 2024 | Vitalpatch Rtm |
| Lexicon Pharmaceuticals, INC. | $17.49 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.42 | 2024 | Xarelto |
| Abiomed | $15.12 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.49 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.